GREY WOLF ANIMAL HEALTH REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
TORONTO, May 22, 2025 /CNW/ - Grey Wolf Animal Health Corp. (TSXV: WOLF) ("Grey Wolf" or the "Company"), a Canadian diversified health company, today announced financial results for the three months ended March 31, 2025.
Highlights
Revenue for the quarter increased year over year by 31.0% to $7.9 million.
Gross profit increased year over year by 34.0% to $4.2 million for the quarter.
Adjusted EBITDA 1 increased year over year by 47.4% to $1.3 million for the quarter.
Launched our first innovative small animal compounded product for the management of feline infectious peritonitis in cats.
"We posted a solid first quarter for both revenue and Adjusted EBITDA," said Angela Cechetto, Chief Executive Officer. Ms. Cechetto went on to say, our growth was driven by an increase in our Pharmacy business by 66.1% to $5.2 million due to an increase in sales of compounded products and the full quarter impact of the acquisition of the Compounding Pharmacy of Manitoba (CPM). Excluding the impact of CPM, we experienced organic growth of 10.8% across our animal and human pharmacy businesses."
Ms. Cechetto continued, "our Animal Health business unit saw a decline in revenue for the quarter of 6.5% to $2.7 million mainly due to a decline in sales of established products and offset by an increase in commissions and new products introduced during the prior year. We continued to experience softness in the veterinary channel carrying into the first quarter; however, we remain confident in the value of our product portfolio for animal health supported by the launch of new products at the end of 2024."
Key Financial Data and Comparative Results
Results of Operations for the First Quarter-ended March 31, 2025
Total revenue for the three-month period ended March 31, 2025 increased 31.0% to $7.9 million over the same period in 2024. Revenue in the Pharmacy business unit increased by 66.1% to $5.2 million from $3.1 million due to an increase in sales of compounded products and the impact of the acquisition of CPM. Revenue in the Animal Health business unit decreased by 6.5% to $2.7 million from $2.9 million mainly due to a decline in sales of established products and offset by an increase in commissions and new products introduced during the prior year.
Gross profits for the three-month period ended March 31, 2025 were 52.6% compared to 51.5% for the same period in 2024. Gross profits were impacted by increased margins in the Pharmacy business unit as a result of decreased material and labour costs and the impact of the CPM acquisition, offset by reduced margins in the Animal Health business unit as a result of product mix.
Total expenses for the three-month period ended March 31, 2025 increased 29.3% to $3.6 million over the same period in 2024. During the three-month period, there was an increase in salary, bonus, and benefits related to operational growth and the CPM Acquisition as compared to the same period in 2024, an increase in freight expenses related to the CPM Acquisition and one-time transaction costs related to the CPM Acquisition.
Adjusted EBITDA 1 was $1.3 million in the first quarter 2025 compared to $0.9 million in the same period in 2024, mainly due to decreased net income for the period after adjusting the related impacts from the CPM Acquisition on interest and accretion expenses and depreciation and amortization cost, and transaction costs specific to the period ended March 31, 2025.
Cash and cash equivalents were $6.8 million at March 31, 2025 compared to $6.4 million at December 31, 2024. The Company generated cash from operations of $1.1 million, which was primarily impacted by net income for the current period offset by changes in non-cash working capital items, most significantly changes in trade and other receivables, inventories, prepaid expenses, and accounts payable and accrued liabilities.
As at March 31, 2025, the Company had outstanding borrowings of $26.4 million, of which $2.1 million are current and $24.3 million are non-current. The Company repaid borrowings of $0.5 million in the quarter. The Company's debt consists of three fixed rate term loans, including a mortgage of $4.4 million secured against the CPM land and building. The Company's net debt/Adjusted EBITDA 1 ratio is approximately 2.9x (2.3x excluding real estate) using 2024 proforma Adjusted EBITDA 1 of $6.7 million.
Grey Wolf's financial statements and accompanying Management Discussion and Analysis for the three months ended March 31, 2025 are available under the Company's profile on www.sedarplus.ca.
1 Non-IFRS Measures
Management uses both IFRS and Non-IFRS Measures to assess the financial and operating performance of the Company's operations. These Non-IFRS Measures are not recognized measures under IFRS, do not have a standardized meaning under IFRS and are unlikely to be comparable to similar measures presented by other companies. The Non-IFRS Measures referenced in this press release includes Adjusted EBITDA. The Company defines Adjusted EBITDA as earnings before transaction costs (including, for greater certainty, transaction costs related to the CPM Acquisition), settlement costs, interest income, interest and accretion expense, income taxes, depreciation of property and equipment, depreciation of right of use assets, amortization of intangible assets, share-based compensation, foreign exchange gains or losses and other income The Company considers Adjusted EBITDA as an additional metric in assessing business performance and an important measure of operating performance and cash flow, providing useful information to help analyze and compare profitability between companies for investors and analysts.
The following table provides a summary of the differences between Grey Wolf's consolidated IFRS and Non-IFRS financial measures, which are reconciled below:
EBITDA and Adjusted EBITDA
About Grey Wolf Animal Health Corp.
Grey Wolf Animal Health Corp., headquartered in Toronto, Canada, is a diversified health company founded by a veterinarian to bring to market a broad portfolio of products that meets the unmet needs of veterinarians, physicians and patients. The Company's strategy is to in-license, acquire or compound prescription and non-prescription products for commercialization in the animal and human health market in Canada. For additional information, please visit: www.greywolfah.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
Forward Looking Statements
Certain information included in this press release contains forward-looking information with the meaning of applicable Canadian securities laws. This information includes statements concerning the Company's objectives, its strategies to achieve those objectives, as well as statements with respect to management's beliefs, plans, estimates, and intentions, and similar statements concerning anticipated future events, results, circumstances, performance or expectations that are not historical facts. Forward-looking information generally can be identified by the use of forward-looking terminology such as "outlook", "objective", "may", "will", "would", "expect", "intend", "estimate", "anticipate", "believe", "should", "plan", "continue", or similar expressions suggesting future outcomes or events or the negative thereof. Such forward-looking information reflects management's beliefs and is based on information currently available. All forward-looking information in this press release is qualified by the following cautionary statements.
Forward-looking information necessarily involve known and unknown risks and uncertainties, which may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, assumptions may not be correct and objectives, strategic goals and priorities may not be achieved. A variety of factors, many of which are beyond the Company's control, affect the operations, performance and results of the Company and its subsidiaries, and cause actual results to differ materially from current expectations of estimated or anticipated events or results.
A more detailed assessment of the risks that could cause actual results to materially differ than current expectations is contained in the Risk Factors section of Grey Wolf's Management Discussion and Analysis for the three months ended March 31, 2025. The forward-looking information included in this press release is made as of the date hereof and should not be relied upon as representing the Company's views as of any date subsequent to the date hereof. Management undertakes no obligation, except as required by applicable law, to publicly update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
SOURCE Grey Wolf Animal Health Corp.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Toronto Star
3 hours ago
- Toronto Star
Competition Bureau reaches deal with Canadian Natural Resources over gas processing
The Canadian government's Competition Bureau website is pictures on a mobile phone and laptop screen in Ottawa on Monday, Oct. 2, 2023. THE CANADIAN PRESS/Sean Kilpatrick skp flag wire: true flag sponsored: false article_type: : sWebsitePrimaryPublication : publications/toronto_star bHasMigratedAvatar : false :
Vancouver Sun
6 hours ago
- Vancouver Sun
Transportation Minister Chrystia Freeland 'dismayed' about BC Ferries' contract with Chinese shipyard
VICTORIA — Federal Transport Minister Chrystia Freeland says she is 'dismayed' that BC Ferries has contracted a Chinese state-owned shipyard to build four new vessels in the current geopolitical context that includes 'unjustified' tariffs on Canada. Freeland says in a letter sent to provincial Transportation Minister Mike Farnworth that she expects BC Ferries to inform her about all measures that it plans to take to 'mitigate any security risks,' including cybersecurity problems that might arise from the decision. BC Ferries announced earlier this month that it has contracted China Merchants Industry Weihai Shipyards to build four new major vessels following a five-year-long procurement process that did not include a Canadian bid. Start your day with a roundup of B.C.-focused news and opinion. By signing up you consent to receive the above newsletter from Postmedia Network Inc. A welcome email is on its way. If you don't see it, please check your junk folder. The next issue of Sunrise will soon be in your inbox. Please try again Interested in more newsletters? Browse here. Freeland adds she is 'surprised' that BC Ferries does not have a mandate for an 'appropriate level' of Canadian content in the procurement given the value of the contract, although the dollar figure hasn't been made public. Farnworth says in a statement that the ministry is reviewing the letter, adding that he has spoken with Freeland about the need to bolster B.C.'s shipbuilding industry. BC Ferries says in a statement that the Chinese bid was 'the strongest bid by a significant margin' and that security is a 'top priority,' adding that all sensitive systems will be sourced separately and independently certified before the vessels enter service. Our website is the place for the latest breaking news, exclusive scoops, longreads and provocative commentary. Please bookmark and sign up for our daily newsletter, Posted, here .
Global News
7 hours ago
- Global News
Slowing sales raise questions about B.C.'s electric vehicle mandate
The British Columbia government is facing renewed questions about whether its aggressive electric vehicle (EV) sales mandates can be achieved. Under current B.C. law, 26 per cent of new light-duty vehicles sold in B.C. must be zero-emission by 2026, a figure climbing to 90 per cent in 2030 and 100 per cent in 2035. B.C. has, to date, been a Canadian leader in EV adoption, with 24 per cent of new vehicle shoppers snapping one up in 2024. But that momentum has run into trouble. Both Ottawa and B.C. phased out their EV subsidies earlier this year, and the auto industry says sales dropped quickly afterward. 2:24 BIV: EV sales in Canada plummet over last year 'The first quarter, we were pushing 19 per cent in adoption rate. In April, it was down to 15 per cent … in May it's about flat with 15 per cent again, so the math is just not there to achieve the 26 per cent in 2026,' said Blair Qualey, president and CEO of the New Car Dealers' Association of B.C. Story continues below advertisement 'The 2030 number is virtually impossible.' Get daily National news Get the day's top news, political, economic, and current affairs headlines, delivered to your inbox once a day. Sign up for daily National newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy Powering British Columbia's roads under a fully electric scenario is another concern. Barry Penner, chair of the Energy Futures Institute, said his group modelled the electricity needs B.C. would face if it did meet its 100 per cent adoption target by 2035. 'It would require, at full implementation, two more site C dams worth of electricity. And this year, we have been importing electricity,' Penner said. 'In the last couple of years, on average, we've imported 20 to 25 percent. Of our domestic electricity needs from outside the province.' Penner said consumer behaviour has also been shifting towards plug-in hybrids, which are cheaper, but have typically not qualified for government rebates. 3:48 B.C. electric vehicle rebate pause The Ministry of Energy and Climate Solutions did not respond to a request for comment by deadline. Story continues below advertisement However, Global News obtained a technical review of B.C.'s Zero-Emission Vehicles Act and Regulation, which appears to show the government is open to adjusting the program. The document shows the province is considering 'several changes' to the legislation 'to respond to current economic conditions, support affordability for consumers, and lessen pressures on automakers.' Those changes include revising the 2030 zero-emission sales targets, amending compliance ratios for battery electric and hydrogen-powered vehicles, changing the percentage of plug-in hybrids dealers can sell under the law, and changing range requirements to ensure more vehicles qualify for credits. The document further notes that challenges to EV adoption still include range anxiety and vehicle price. 'They're more expensive on average than a non-electric vehicle. Some studies suggest about $8,000 per vehicle,' Penner said. 'Internal government polling shows almost 60 per cent of British Columbians say that's the number one problem buying an electric cars is the cost and yet what have they done? They've removed the rebate.' B.C. has been working to upgrade infrastructure; BC Hydro has installed about 600 fast chargers around the province, with more to come. 'And while the province has paused EV subsidies for now, the policy document hints that it is looking at 'new initiative agreement pathways to support affordability for consumers.' Story continues below advertisement The province is also conducting a wider review of its entire CleanBC program. Qualey said new rebates would help the situation, but argued that even with them in place, the targets are too aggressive. 'Ideally, we would like a pause on all of it right now to continue the conversation so the manufacturers, who are the obligated parties in all of this, can sit with government … (and determine) what targets are achievable,' he said.
